Clinical Trial Update: Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the immunogenicity of the live attenuated chimeric Japanese encephalitis vaccine IMOJEV as a booster in Thai children previously primed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• CD.JEVAX (Japanese encephalitis vaccine)
• IMOJEV

Snippet

Sponsor: Siriraj Hospital | Conditions: Encephalitis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-07